1/94
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
COMPLEMENT SYSTEM
is a complex series of more than 50 proteins of the innate immune system.
COMPLEMENT SYSTEM
o Pro-inflammatory effects:
1. opsonizes and tags foreign invaders for
clearance
2. directs the adaptive immune system to the site of
infection
3. increases vascular permeability
4. recruits monocytes and neutrophils to the area of
antigen concentration,
5. triggers secretion of immuno-regulatory
molecules that amplify the immune response
6. lyse foreign cells: end product of its activation
COMPLEMENT SYSTEM
“Housekeeping” roles: recognizes cellular debris, such as apoptotic cells and immune complexes, tagging it for removal by innate immune cells.
Anaphylotoxin
Chemotaxin
Opsonin
Cell lysis
COMPLEMENT SYSTEM FUNCTIONS:
C3a
C4a
C5a
Anaphylotoxin:
C5a
Chemotaxin:
C3b
Opsonin:
Anaphylotoxin
Binds to mast cells/basophils and causes them to discharge their cytoplasmic granules (histamine)
Causes vasodilation and increased vascular permeability
Chemotaxin
Triggers the movement of cells in a specific direction
Opsonin
immune adherence
Classical pathway
Alternative pathway
Lectin pathway
Complement system can be activated in three different ways.
Classic pathway
involves 9 proteins, antibody-dependent
Alternative pathway
Lectin pathway
antibody-independent
1. Factor B
2. Factor D
3. C3b,Bb
4. Cobra venom factor (CVF)
5. P (Properdin
Five other proteins in the Alternative pathway
Paul Ehrlich
Complement was so coined by ____ because it complements the action of antibody in destroying microorganisms.
Jules Bordet
was awarded the Nobel Prize in 1919 for his role in elucidating the nature of complement
Cascade
Complement activation is described as a
56C
Complemetn system is destroyed by heating sera at ___ for 30 minutes
IgM and IgG
are the only Abs that react with Complement System
C1 components (Intestinal epithelial cells)
Factor D (Adipose tissue)
Most plasma complement proteins are synthesized in the liver, except
Monocytes and Macrophages
additional sources C1, C2, C3, and C4
Classical Pathway
o The first pathway to be discovered
o Responsible for complement activation on most antibody sensitized cells
✓ is the main antibody-directed mechanism for triggering complement activation
IgM
most efficient of the activating immunoglobulins because it has multiple binding sites for complement.
✓ takes only one molecule to activate complement
Two IgG
__ molecules must attach to antigen within 30 to 40 nm of each other before complement can bind
C1
Recognition unit
C4
C3
C2
Activation unit
C5
C6
C7
C8
C9
Membrane attack unit aka C5b-9
C5b-9
membrane attack unit is also known as
C1
a tri-molecular complex (C1q, C1r, C1s) held together by Calcium
C1q
__ unit is the part that binds to antibody molecules,
C1r
C1s
__ subunits generate enzyme activity to begin the cascade.
C4
is the second most abundant complement protein, a serum concentration of approximately 600 µg/mL.
C4a
acts as anaphylotoxin
30 molecules
for every C1 molecule approximately _____ of C4 are split and attached
Magnesium ions
When combined with C4b in the presence of ____, C2 is cleaved by C1s to form the fragments
70 kDa
C2a molecular weight
34 kDa
C2b molecular weight
15 sec to 3 min
C4b combines with C2a to form C4bC2a (C3 convertase) ✓ the half-life is estimated to be between
C3 convertase
C4bC2a also known as
C3
the major and central constituent of the complement system, is present in the plasma in a concentration of 1 mg/mL to 1.5 mg/mL
C4bC2a (C3 convertase)
C3 is cleaved into two fragments, C3a and C3b by
Cleavage of C3 to C3b
most significant step in the entire process of complement activation.
C3b
Is an opsonin
C5 convertase: C4b2a3b
C3b attaches to C3 convertase forming
C5a
released In the circulation as a chemotaxin and anaphylotoxin
C5b
which attaches to the cell membrane, forming the beginning of the MAC
MAC
The cleaving of C5 with deposition of C5b at another site on the cell membrane constitutes the beginning of the
MAC
C6 is bound to C5b, subsequent binding of C7, C8, and multiple molecules of C9 occurs. The complex of C5b-C6-C7-C8 and C9 is known as C5b-9 or the
C8
Inserted into the cell membrane and disrupts it
C9
Enhance the activity of C8
C9
In absence of __, cells will still undergo lysis but at a slower rate.
Cell lysis
End result of Classical pathway
Anaphylotoxins: C3a, C4a and C5a
• small pro-inflammatory peptide that causes increased vascular permeability, contraction of smooth muscle, and release of histamine from basophils and mast cells
• C5a causes neutrophils to release proteolytic enzymes, oxygen radicals, and prostaglandins, which aid in the destruction of foreign antigens
Chemotaxin C5a
• cells are directed to the source of antigen concentration.
• neutrophils migrate from blood vessels to the tissues and tend to aggregate
Opsonins: C4b, C3b, iC3b, and C3dg
binding to specific receptors on erythrocytes, neutrophils, monocytes, and macrophages to facilitate phagocytosis and clearance of foreign substances or cellular debris
Alternative pathway
o First described by Pillemer and his associates in the early 1950s
originally named for the protein Properdin
Bypasses C1, C4 and C2, starts at C3 • Activation is initiated when C3b is deposited on the bacterial cell surface and binds with Factor B.
✓ bacterial cell walls: especially those containing
lipopolysaccharide
✓ fungal cell walls
✓ Yeast
✓ Viruses
✓ virally infected cells
✓ tumor cell lines
✓ some parasites, especially trypanosomes.
• serve as sites for binding the complex C3bBb, one of the key
products of this pathway
Triggering substances of alternative pathway:
Lectin pathway
o aka MBL pathway (mannose-binding lectin or
mannan-binding lectin pathway)
o the most ancient pathway
o it involves nonspecific recognition of carbohydrates
that are common constituents of microbial cell walls
and that are distinct from those found on human
cell surfaces.
✓ Antibody independent
o plays an important role as a defense mechanism in
infancy
✓ during the interval between the loss of maternal antibody
and the acquisition of a full-fledged antibody response to
pathogens.
Lectins, Ficolins, and Collectins
• The role C1q serves
in the classical
pathway is filled by
these classes of
recognition molecules
in the lectin pathway
• Their structure is
similar to that of C1q
ficolins and collectins
can bind to pathogen-associated molecular patterns to activate the lectin pathway
mannose-binding lectin (MBL)
• binds to mannose or
related sugars in a
calcium-dependent
manner to initiate this
pathway
• detects glycoproteins
or carbohydrates of a
wide variety of
microorganisms, such
as bacteria, yeasts,
viruses, and some
parasites
MASP-2
• autoactivates once it bind to a cellular surface
• homologous to C1s
• takes the active role in cleaving C4 and C2
• Once C4 and C2 are cleaved, the rest of the pathway is
identical to the classical pathway. ( from the activation of C4
and C2, lectin and classical pathway are identical)
C1 inhibitor (C1-INH)
• Its main role is to inactivate C1 by binding
to the active sites of C1r and C1s.
• C1r and C1s become instantly and
irreversibly dissociated from C1q.
• inactivates MASP-2, binding to the MBLMASP complex, thus halting the lectin
pathway
C4BP, CR1, MCP, DAF
Cofactors of FACTOR I in inactivating C3b and C4b (C3 convertase)
C4-binding protein (C4BP)
• Acts as a cofactor with I to inactivate C4b
• C4BP blocks C4b from binding to C2 and directs degradation by Factor I
CR1, also known as CD35
It binds C3b and C4b but has the greatest affinity for C3b. Once bound to CR1, both C4b and C3b can then be degraded by Factor I.
• CR1 is a key receptor on platelets and red blood cells (RBCs)
✓ bind C3b-coated immune complexes → facilitate their trafficking to the liver and spleen → It is there that fixed tissue macrophages strip the immune complexes from the RBCs, process the complexes → return the RBCs intact to the circulation.
CR1
is a key receptor on platelets and red blood cells (RBCs)
MCP (membrane cofactor protein), or CD46
• Not found in erythrocytes (RBCs)
• most efficient cofactor for Factor I– mediated cleavage of C3b.
• serves as a cofactor for cleavage of C4b, but it is not as effective as C4BP.
• Alternative pathway: binding of Factor B to C3b is inhibited.
DAF- Decay-Accelerating Factor or CD55
• can bind to both C3b and C4b
• dissociates C2a or Bb from binding sites, thus preventing
formation of C3 convertase
✓ It does not prevent initial binding of either C2 or Factor B to the cell but
can rapidly dissociate both from their binding sites, thus preventing the
assembly of an active C3 convertase.
bystander lysis
The presence of DAF on host cells protects them from
Factor H
• principal soluble regulator of the alternative pathway
• Prevents binding of Factor B to C3b
✓binds to C3bBb, Bb becomes displaced
• Cofactor with I to inactivate C3b
✓When Factor I binds, a conformational change takes place that
allows it to cleave C3b into either C3f and iC3b.
CD35
CR1 aka
CD21
CR2 aka
CR2 aka CD21
• found mainly on B lymphocytes and follicular dendritic cells
• Ligands for CR2: degradation products of C3b, such as C3dg, C3d, and iC3b
• Receptor for Epstein-Barr virus to enter B cells
• B-cell co-receptor for antigen with CD19
✓ binds complement-coated antigen and cross-links it to membrane immunoglobulin
to activate B cells.
✓ In this manner, immune complexes are more effective at enhancing B-cell
differentiation and producing memory cells than is antigen by itself.
CR3 (CD11b/CD18)
• monocytes, macrophages, neutrophils, and natural killer (NK) cells
• adhesion and increased activity of phagocytic cells
• specifically binds particles opsonized with iC3b, a C3b degradation product.
✓ It does this in a calcium-dependent manner.
✓ The CR3 receptor plays a key role in mediating phagocytosis of particles coated with these complement
fragments
CR4 (CD11c/CD18) receptor
• Adhesion and increased activity of phagocytic cells
• Their function appears to be similar to that of CR3, and they
may assist neutrophil adhesion to the endothelium during
inflammation
✓It is activated systemically on a large scale, as in gram-negative
septicemia.
✓It is activated by tissue necrosis, such as myocardial infarction.
✓lysis of RBCs occurs
Complement can be harmful if;
Septicemia caused by gram negative bacteria
large quantities of C3a and C5a are generated, leading to neutrophil aggregation and clotting. Damage to the tiny pulmonary capillaries and interstitial pulmonary edema may result.
Tissue injury following obstruction of the blood supply
occurs in a myocardial infarction or heart attack, can cause
complement activation and deposition of MACs on cell surfaces.
Receptors for C3a and C5a have been found in coronary plaques,
indicating that complement components may increase the damage to
heart tissue.
Alternative pathway hemolytic assay (AH50)
ELISA (Enzyme-Linked Immunosorbent Assay)
Alternative and Lectin Pathway Assays
Alternative pathway hemolytic assay (AH50)
• Performed in the same manner as the CH50, except magnesium chloride and
ethylene glycol tetra acetic acid (EGTA) are added to the buffer, and calcium is left
out. This buffer chelates calcium, which blocks classical pathway activation.
• Rabbit red cells are used as the indicator: an ideal surface for alternative pathway
activation.
• A low or absent AH50 value indicates a deficiency in one or more of the alternative
pathway components (Factor B, D, Properdin) or terminal components (C5-C9)
ELISA (Enzyme-Linked Immunosorbent Assay)
• Microtiter plates are coated with a ligand such as mannan. The patient serum is
added to the wells, allowing MBL to bind to the mannan and activate the pathway.
• The level of activated C4b is then measured using an enzyme-linked antibody that
produces color change
• The intensity of the color is proportional to the activity of the lectin pathway
EDTA (Ethylenediaminetetraacetic acid)
only anticoagulant that completely inhibits any complement activation ex vivo
✓ chelate the calcium necessary for classical and lectin pathway activation
✓ to avoid the cross-pathway cleavage of complement during the clotting process.
EDTA-plasma
should be used for the quantification of complement components and their activation products.
n C3b and C5b-9 fragments
If serum tube is used by mistake, the clotting process will produce a large increase in __ post draw
nephelometry and immunoturbidimetry.
The most common methods for measuring individual complement proteins are
Nephelometry
measures the concentration of an individual complement protein according to the amount of light scattered by the antigen–antibody mixture
Immunoturbidimetry
is based on the reduction in light transmission resulting from immune complex formation
Hemolytic titration (CH50) assay
Assays for the Classical Pathway
Hemolytic titration (CH50) assay
• measures the amount of patient serum required to lyse
50% of a standardized concentration of antibodysensitized sheep erythrocytes.
• proteins from C1 to C9 are necessary for this to occur,
functional or quantitative absence of any one
component will result in an abnormal CH50, essentially
reducing this number to zero.
• The titer is expressed in CH50 units, which is the
reciprocal of the dilution that is able to lyse 50% of the
sensitized RBCs.
• The degree of hemolysis is measured by the amount of
hemoglobin released into the solution. A low CH50
value suggest a deficiency in one of the proteins from
C! to C9
Sutimlimab
Cold Agglutinin Disease (CAD)
Eculizumab
Paroxysmal Nocturnal Hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS)